Company
Institut de Recherches Internationales Servier (I.R.I.S.)
Institut de Recherches Internationales Servier (I.R.I.S.) has 1 drug tracked on RxWires: 1 in Phase 2.
Pipeline
| Drug | Phase | Indication |
|---|---|---|
| S247240 Low dose | Phase 2 | Fragile X Syndrome (FXS) |
Latest
No recent events.
Follow Institut de Recherches Internationales Servier (I.R.I.S.) on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.
Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.